Published in Lancet on August 04, 2001
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol (2006) 4.34
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther (2012) 3.57
Recent advances in coeliac disease. Gut (2006) 3.20
Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol (2012) 2.78
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ (2004) 2.29
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut (2007) 1.92
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol (2010) 1.88
Hematologic manifestations of celiac disease. Blood (2006) 1.87
The Canadian Celiac Health Survey. Dig Dis Sci (2007) 1.75
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res (2005) 1.63
Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol (2006) 1.51
Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis. Gut (2014) 1.47
Celiac disease and risk of fracture in adults--a review. Osteoporos Int (2014) 1.43
Celiac disease and autoimmune thyroid disease. Clin Med Res (2007) 1.42
Coeliac disease. J Clin Pathol (2005) 1.38
European and North American populations should be screened for coeliac disease. Gut (2003) 1.32
Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity". World J Gastroenterol (2007) 1.30
Burden of celiac disease in the Mediterranean area. World J Gastroenterol (2011) 1.29
Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology (2010) 1.29
Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol (2008) 1.23
Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Dig Dis Sci (2011) 1.21
The changing clinical presentation of coeliac disease. Arch Dis Child (2006) 1.19
Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol (2002) 1.18
A non-human primate model for gluten sensitivity. PLoS One (2008) 1.17
Advances in diagnosis and management of celiac disease. Gastroenterology (2015) 1.17
The gluten-free diet: testing alternative cereals tolerated by celiac patients. Nutrients (2013) 1.13
Factors that influence adherence to a gluten-free diet in adults with celiac disease. Dig Dis Sci (2008) 1.12
The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10
Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol (2007) 1.07
Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging (2003) 1.06
Reduced-gliadin wheat bread: an alternative to the gluten-free diet for consumers suffering gluten-related pathologies. PLoS One (2014) 1.05
Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. PLoS One (2012) 1.04
Oral enzyme therapy for celiac sprue. Methods Enzymol (2012) 1.03
Complications of coeliac disease: are all patients at risk? Postgrad Med J (2006) 0.98
Screening for celiac disease in average-risk and high-risk populations. Therap Adv Gastroenterol (2012) 0.97
Celiac disease in South-West of Iran. World J Gastroenterol (2006) 0.97
Refractory celiac disease: from bench to bedside. Semin Immunopathol (2012) 0.95
Mortality in celiac disease. Nat Rev Gastroenterol Hepatol (2010) 0.94
Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog (2008) 0.91
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
A case-control study of presentations in general practice before diagnosis of coeliac disease. Br J Gen Pract (2007) 0.90
The impact of misdiagnosing celiac disease at a referral centre. Can J Gastroenterol (2009) 0.89
Indian task force for celiac disease: current status. World J Gastroenterol (2009) 0.89
Geographic trends and risk of gastrointestinal cancer among patients with celiac disease in Europe and Asian-Pacific region. Gastroenterol Hepatol Bed Bench (2013) 0.88
The changing frequency of celiac disease diagnosed at the Stollery Children's Hospital. Can J Gastroenterol (2010) 0.86
Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis. Ont Health Technol Assess Ser (2011) 0.86
Celiac disease in the Turkish population. Dig Dis Sci (2005) 0.86
Duodenal Signet Ring Cell Carcinoma in a Celiac Patient. Case Rep Gastroenterol (2009) 0.84
Subclinical celiac disease and crystal-induced kidney disease following kidney transplant. Am J Kidney Dis (2012) 0.83
Serological screening for celiac disease in schoolchildren in Jordan. Is height and weight affected when seropositive? Ital J Pediatr (2010) 0.83
PROgnosticating COeliac patieNts SUrvivaL: the PROCONSUL score. PLoS One (2014) 0.83
Coeliac disease: is case finding the correct ethical and logistical approach? Gut (2003) 0.83
Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance. Interdiscip Toxicol (2013) 0.83
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions. J Am Chem Soc (2015) 0.82
The Spectrum of Differences between Childhood and Adulthood Celiac Disease. Nutrients (2015) 0.80
Analysis of the absolute risks in coeliac disease indicates the importance of the prevention of osteoporosis. Gut (2007) 0.80
Risk of colorectal adenomas in patients with coeliac disease. Aliment Pharmacol Ther (2010) 0.80
From hyperplasia to T cell lymphoma. Gut (2002) 0.80
Benign small bowel thickening and lymphadenopathy: a manifestation of celiac disease. Dig Dis Sci (2008) 0.79
Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase. Appl Microbiol Biotechnol (2014) 0.79
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. BMC Gastroenterol (2014) 0.79
Celiac disease: an underappreciated issue in women’s health. Womens Health (Lond Engl) (2010) 0.79
Celiac disease: Serologic prevalence in patients with irritable bowel syndrome. J Res Med Sci (2012) 0.79
The prevalence of celiac disease in blood donors in Iceland. Dig Dis Sci (2008) 0.79
Celiac sprue: a unique autoimmune disorder. Expert Rev Clin Immunol (2009) 0.78
Limited utilization of serologic testing in patients undergoing duodenal biopsy for celiac disease. BMC Gastroenterol (2013) 0.78
Enteropathy associated T cell lymphoma: common in coeliac disease. BMJ Case Rep (2009) 0.78
Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach. Dig Dis Sci (2003) 0.77
Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther (2016) 0.77
Aspects of digestive tract tumors in Down syndrome: a literature review. Dig Dis Sci (2006) 0.77
Complications in celiac disease under gluten-free diet. Dig Dis Sci (2008) 0.76
Duodenal adenocarcinoma might be the cause of intractable nausea and vomiting in patient with coeliac disease. Gastroenterol Hepatol Bed Bench (2012) 0.76
Cross-sectional study of coeliac autoimmunity in a population of Vietnamese children. BMJ Open (2016) 0.75
Small Bowel Adenocarcinoma in a Patient with Coeliac Disease: Case Report and Review of the Literature. Case Rep Gastroenterol (2010) 0.75
Practical considerations for the identification and follow-up of children with celiac disease. Paediatr Child Health (2004) 0.75
Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients. Nutrients (2017) 0.75
Does Celiac Disease Influence Survival in Sepsis? A Nationwide Longitudinal Study. PLoS One (2016) 0.75
Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-based Study. Gastroenterology (2016) 0.75
Cost effectiveness of routine duodenal biopsies in iron deficiency anemia. World J Gastroenterol (2016) 0.75
Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries. Can J Gastroenterol Hepatol (2015) 0.75
Does celiac disease influence survival in lymphoproliferative malignancy? Eur J Epidemiol (2013) 0.75
Celiac disease. CME update for family physicians. Can Fam Physician (2004) 0.75
Population based screening for coeliac disease: patient's choice or doctor's decision. Gut (2004) 0.75
Small bowel adenocarcinoma in a patient with Coeliac disease: A case report. Cases J (2008) 0.75
Do we need to worry about eating wheat? Nutr Bull (2016) 0.75
Speeding up coeliac disease diagnosis in cardiological settings. Arch Med Sci (2010) 0.75
Celiac Disease Associated with a Benign Granulomatous Mass Demonstrating Self-Regression after Initiation of a Gluten-Free Diet. Case Rep Gastroenterol (2017) 0.75
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Alcohol and coronary heart disease: a meta-analysis. Addiction (2000) 3.72
Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76
Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology (1998) 2.68
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut (2009) 2.48
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Extensive necrosis of gastric mucosa following injection therapy of bleeding peptic ulcer. Endoscopy (1990) 2.38
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann Oncol (2007) 2.30
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis (2001) 2.30
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
Screening test for coeliac disease. Lancet (1997) 2.23
Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology (1997) 2.22
Intestinal permeability in Crohn's disease patients and their first degree relatives. Dig Liver Dis (2001) 2.20
Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol (2014) 2.15
Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet (2000) 2.09
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92
Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction (1999) 1.90
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol (2011) 1.84
Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology (1996) 1.83
Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis (2004) 1.82
Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology (2000) 1.79
The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol (1999) 1.76
Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease. Am J Clin Pathol (2001) 1.74
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. Gastroenterology (1992) 1.72
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
The incidence of coeliac disease in adult first degree relatives. Dig Liver Dis (2007) 1.69
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry (1999) 1.68
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol (1994) 1.64
A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol (2011) 1.62
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. Dig Liver Dis (2005) 1.61
Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol (1999) 1.60
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol (2011) 1.57
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig Liver Dis (2005) 1.57
Tissue transglutaminase antibodies for coeliac disease screening. Ital J Gastroenterol Hepatol (1998) 1.57
Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency. Pediatr Allergy Immunol (2003) 1.55
Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut (2005) 1.55
Clinical features of coeliac disease. Dig Liver Dis (2002) 1.51
Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun (1996) 1.51
Should liver metastases of breast cancer be biopsied to improve treatment choice? Ann Oncol (2011) 1.50
Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis (2002) 1.50
Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am J Gastroenterol (1991) 1.48
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
Quality control study of H2 breath testing for the diagnosis of carbohydrate malabsorption in Italy. The "Tenue Club" Group. Ital J Gastroenterol Hepatol (1997) 1.48
Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis (2008) 1.46
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis (2002) 1.44
Excess prevalence of extracranial carotid artery lesions in renovascular hypertension. Am J Hypertens (1992) 1.43
UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen. Oncology (2008) 1.43
Analysis of local and regional recurrences in breast cancer after conservative surgery. Ann Oncol (2009) 1.43
Ultrasound changes in abdominal echinococcosis treated with albendazole. J Clin Ultrasound (1991) 1.42
No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol (1995) 1.42
Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change. Gastroenterology (1981) 1.41
IgA antibodies to endomysium, gliadin, and reticulin in silent coeliac disease. Lancet (1992) 1.40
Genetic test for lactase non-persistence and hydrogen breath test: is genotype better than phenotype to diagnose lactose malabsorption? Dig Liver Dis (2008) 1.39
Endomysial and tissue transglutaminase antibodies in coeliac sera: a comparison not influenced by previous serological testing. Scand J Gastroenterol (2001) 1.39
Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia (1992) 1.39
[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. Minerva Med (1992) 1.39
Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol (1989) 1.38
Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease. Gut (2004) 1.38
Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci (1986) 1.37
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease. Gut (1985) 1.35
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther (2006) 1.33
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther (2004) 1.32
Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet (1990) 1.30
Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: a comparison between linear measurement, stereology, and computer aided microscopy. J Clin Pathol (1985) 1.30
Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut (2005) 1.25
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut (2009) 1.22
Action anticipation beyond the action observation network: a functional magnetic resonance imaging study in expert basketball players. Eur J Neurosci (2012) 1.21
Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis. J Clin Gastroenterol (1993) 1.20
Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia (2006) 1.19
Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol (2001) 1.17
Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol (1997) 1.17
Gluten specific suppressor T cell dysfunction in coeliac disease. Gut (1986) 1.17
Twenty-four hour recordings of colonic motility in patients with diverticular disease: evidence for abnormal motility and propulsive activity. Dis Colon Rectum (2001) 1.17
Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology (1995) 1.16
Jejunal intraepithelial lymphocytes in coeliac disease: are they increased or decreased? Gut (1984) 1.15
Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet (1985) 1.14
Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J Clin Invest (1991) 1.12
Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol (2001) 1.12
Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut (1983) 1.12
Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone (1996) 1.11
Return of splenic function after splenectomy: how much tissue is needed? Br Med J (Clin Res Ed) (1984) 1.11
Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2000) 1.11
The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10
Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther (2005) 1.10